Clinical Pharmacological Study of ASP1941 - A Clinical Pharmacological Study of ASP1941 in Subjects With Type 1 Diabetes Mellitus
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Astellas Pharma
- 13 Apr 2016 Status changed from active, no longer recruiting to completed.
- 17 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 30 Sep 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.